ClinicalTrials.Veeva

Menu

PET Study of Acetylcholine Esterase Activity in Alzheimer's Disease

S

San Donato Group (GSD)

Status

Completed

Conditions

Alzheimer Disease

Treatments

Diagnostic Test: PET with 11C MP4

Study type

Observational

Funder types

Other

Identifiers

NCT06180252
MP4-FIN2001

Details and patient eligibility

About

The aim of this study is to understand regional variations in acetylcholine esterase activity in Alzheimer's disease. In this study the aim is to identify by PET the physiological values of the regional activity of acetylcholine esterase using the 11C PM4 tracer and to study by PET and 11C PM4 the brain activity of acetylcholine esterase in a group of patients with Alzheimer's disease, enrolled according to the inclusion and exclusion criteria. The PET data will be correlated with the clinical, neuropsychological and morphological data acquired by MRI and with the clinical-cognitive outcome.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with Alzheimer's disease;
  • patients must have undergone an instrumental morphological examination to exclude other neurological pathologies.

Exclusion criteria

  • positive history of major head trauma;
  • clinically active somatic diseases.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems